Alopecia Areata Archives - Medical Conferences

Deuruxolitinib significantly improves hair satisfaction in AA

Presented By

Dr Paradi Mirmirani, Kaiser Permanente Vallejo Medical Center, USA

Trial

THRIVE-AA

Conference

EADV 2024

Type

Peer-reviewed article

6 November 2024 12:56

What’s new in clinical dermatology?

Presented By

Dr Tamar Nijsten, Erasmus University Medical Centre, the Netherlands

Conference

DDD 2024

Type

Peer-reviewed article

31 May 2024 13:31

Baricitinib maintains regrowth of hair, eyebrows, and eyelashes over 3 years

Presented By

Prof. Maryanne Senna, Harvard Medical School, USA

Trial

BRAVE-AA

Conference

AAD 2024

Type

Peer-reviewed article

22 April 2024 16:43

Botanical drug solution leads to sustained hair regrowth in paediatric alopecia

Presented By

Prof. Bianca Piraccini, University of Bologna, Italy

Trial

RAAINBOW

Conference

AAD 2024

Type

Peer-reviewed article

22 April 2024 15:14

SGLT2 inhibition: A possible mode-of-action for inflammatory skin diseases?

Presented By

Allison Holt, UMass Chan Medical School, USA

Conference

AAD 2024

Type

Peer-reviewed article

22 April 2024 15:06

Ritlecitinib also effective in patients with total hair loss

Presented By

Dr Melissa Piliang, Cleveland Clinic, USA

Trial

Phase 3, ALLEGRO

Conference

AAD 2024

Type

Peer-reviewed article

22 April 2024 14:57

JAK3/TEC inhibition achieves clinically meaningful responses in AA

Presented By

Dr Athanasios Tsianakas, Fachklinik Bad Bentheim, Germany

Trial

Phase 3, ALLEGRO-LT

Conference

EADV 2023

Type

Peer-reviewed article

28 November 2023 10:31

Alopecia areata: remarkable regrowth rates with deuruxolitinib

Presented By

Prof. Brett King, Yale University School of Medicine, USA

Trial

Phase 3, THRIVE-AA

Conference

EADV 2023

Type

Peer-reviewed article

28 November 2023 10:28

Botanical drug solution improves hair regrowth in children and adolescents with AA

Presented By

Prof. Ulrike Blume-Peytavi, Charité – Berlin University Medicine, Germany

Trial

RAAINBOW

Conference

EADV 2023

Type

Peer-reviewed article

28 November 2023 10:23

Patients with AA report high long-term regrowth rates with baricitinib

Presented By

Dr Maryanne Senna, Harvard Medical School, MA, USA

Trial

BRAVE-AA1 and BRAVE-AA2

Conference

WCD 2023

Type

Peer-reviewed article

31 August 2023 15:22

Can ritlecitinib deliver long-term efficacy in alopecia areata?

Presented By

Prof. Melissa Piliang, Cleveland Clinic, OH, USA

Trial

Phase 3, ALLEGRO

Conference

WCD 2023

Type

Peer-reviewed article

31 August 2023 15:18

TikTok videos on hair disorders lack reliability

Presented By

Dr Betty Nguyen, University of Miami, FL, USA

Conference

WCD 2023

Type

Peer-reviewed article

31 August 2023 15:14

JAK inhibitor deuruxolitinib shows encouraging hair re-growth in alopecia areata

Presented By

Dr Maryanne Senna, Lahey Hospital and Medical Center, MA, USA

Trial

Phase 3, THRIVE-AA1

Conference

AAD 2023

Type

Peer-reviewed article

15 May 2023 12:41

The rise of JAK inhibitors for alopecia areata

Presented By

Dr Brett King, Yale University, CT, USA

Conference

DDD 2023

Type

Peer-reviewed article

10 May 2023 13:47

Long-term improvement in alopecia areata with ritlecitinib therapy

Presented By

Dr Athanasios Tsianakas, Fachklinik Bad Bentheim, Germany

Trial

Phase 3, ALLEGRO-LT

Conference

EADV 2022

Type

Peer-reviewed article

5 November 2022 09:30

Deuruxolitinib achieves hair regrowth, even in patients with severe alopecia areata

Presented By

Prof. Brett King, Yale University School of Medicine, CT, USA

Trial

Phase 3, THRIVE-AA1

Conference

EADV 2022

Type

Peer-reviewed article

5 November 2022 09:18

EADV 2022 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

EADV 2022

27 September 2022 11:49

No adverse pregnancy outcomes in patients exposed to baricitinib

Conference

SPIN 2022

Type

Peer-reviewed article

26 August 2022 10:47

Alopecia areata: light at the end of the tunnel

Presented By

Prof. Maryanne Senna , Harvard Medical School, MA, USA

Trial

Phase 3, BRAVE-AA1, BRAVE-AA2

Conference

SPIN 2022

Type

Peer-reviewed article

26 August 2022 10:01

Alopecia areata pathogenesis: known genetic background, unknown environmental triggers

Presented By

Prof. Rodney Sinclair , University of Melbourne, Australia

Conference

SPIN 2022

Type

Peer-reviewed article

26 August 2022 09:56

Alopecia areata: 1-year baricitinib treatment increases success

Presented By

Prof. Brett King, Yale School of Medicine, USA

Trial

Phase 3, BRAVE-AA1; BRAVE-AA2

Conference

AAD 2022

Type

Peer-reviewed article

17 May 2022 10:35

JAK1/2: A promising novel treatment target in alopecia areata

Presented By

Prof. Brett King, Yale University School of Medicine, USA

Trial

Phase 3, BRAVE-AA1; BRAVE-AA2

Conference

EADV 2021

Type

Peer-reviewed article

18 November 2021 13:12

Alopecia areata: encouraging response rates with JAK3/TEC inhibition

Presented By

Prof. Brett King, Yale University School of Medicine, USA

Trial

ALLEGRO

Conference

EADV 2021

Type

Peer-reviewed article

18 November 2021 13:11

Allergies: an underrated factor in alopecia pathogenesis

Presented By

Prof. Natasha Mesinkovska, UC Irvine School of Medicine, CA, USA

Conference

AAD VMX 2021

Type

Peer-reviewed article

7 June 2021 13:45

Botulinum toxin A: a contradictory role in hair loss

Presented By

Prof. Natasha Mesinkovska, UC Irvine School of Medicine, CA, USA

Conference

aad vmx 2021

Type

Peer-reviewed article

7 June 2021 13:21

JAK inhibitors in AA: re-establishing the immune privilege of hair follicles

Presented By

Prof. Taisuke Ito, Hamamatsu University School of Medicine, Japan

Conference

EADV 2020

Type

Peer-reviewed article

17 December 2020 14:27

Novel JAK1/2 inhibitor shows remarkable efficacy in alopecia areata

Presented By

Dr James Cassella

Conference

EADV 2019

Type

Peer-reviewed article

9 December 2019 18:54

Novel treatment options in alopecia areata and vitiligo

Presented By

Prof. Brett King, Yale University School of Medicine, USA

Conference

WCD 2019

Type

Peer-reviewed article

26 August 2019 18:20

JAK1/2 inhibitor effective in alopecia areata

Presented By

James Cassella, Concert Pharmaceuticals, USA

Conference

AAD 2019

Type

Peer-reviewed article

19 April 2019 21:21

JAK inhibitors: a pathogenesis-directed therapy for alopecia areata

Presented By

Prof. Brittany Craiglow, Yale University School of Medicine, USA

Conference

AAD 2019

Type

Peer-reviewed article

19 April 2019 19:10

A glimpse into the future

Presented By

Prof. Wilma Bergfeld, Cleveland Clinic, USA

Conference

AAD 2018

Type

Peer-reviewed article

20 December 2018 18:08

New agents and combination therapy

Presented By

Prof. Wilma Bergfeld, Cleveland Clinic, USA

Conference

AAD 2018

Type

Peer-reviewed article

20 December 2018 17:11